Infinitude Clothing, designer and manufacturer of professional medical apparel, recently partnered with Noble Biomaterials to incorporate the proven performance of X-STATIC® Antimicrobial Technology in a new line of premium fashion-forward medical scrubs, white coats, surgical hats/caps and stethoscope covers. The new apparel line from Infinitude features a blend of trend-setting style, quality and comfort. Soft, durable and functional, the brand will offer scrubs in ready-made designs in an array of colors as well as a wide range of made-to-order individualized designs.
Healthcare-associated infections (HAIs) are the fourth leading cause of death in the United States, resulting in approximately 99,000 deaths annually - more than breast cancer, diabetes, influenza and car accidents. Moreover, 90 percent of the patient contact environment is made of up soft surface fabrics such as scrubs and lab coats and these have been proven to be contaminated. X-STATIC antimicrobial technology permanently bonds textile fibers with a layer of 99.9 percent pure metallic silver. The silver layer creates an ionic shield that inhibits the growth of bacteria and fungi directly on the surface of the fabric. It provides permanent protection for patients and staff between laundering, lasts the life of the product and since its inherent in the fabric, does not require modification in staff behavior.
We recognize the importance of infection control in healthcare today, says Dr. Gil Ortega, board-certified orthopedic surgeon and founder of Infinitude Clothing. Infinitude Clothing powered by X-STATIC technology will allow our customers to not only look and feel great, but better equip them in the battle against healthcare associated infections.
Infinitude Clothing designs and manufactures premium medical apparel for medical professionals.Â
X-STATIC® is a registered trademark of Noble Fiber Technologies, LLC. Noble Biomaterials, Inc. is a global leader in bacterial management solutions. The company develops, manufactures, sells and markets advanced antimicrobial technologies designed to manage all forms of bacterial contamination.
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.